4.7 Article

Cited2 Is an Essential Regulator of Adult Hematopoietic Stem Cells

Journal

CELL STEM CELL
Volume 5, Issue 6, Pages 659-665

Publisher

CELL PRESS
DOI: 10.1016/j.stem.2009.11.001

Keywords

-

Funding

  1. John Fell OUP Research Fund
  2. Leukaemia Research Fund
  3. Medical Research Council
  4. Wellcome Trust
  5. MRC [G0501838, MC_U137973817, G0801073] Funding Source: UKRI
  6. Medical Research Council [MC_U137973817, G0501838, G0801073] Funding Source: researchfish

Ask authors/readers for more resources

The regulatory pathways necessary for the maintenance of adult hematopoietic stem cells (HSCs) remain poorly defined. By using loss-of-function approaches, we report a selective and cell-autonomous requirement for the p300/CBP-binding transcriptional coactivator Cited2 in adult HSC maintenance. Conditional deletion of Cited2 in the adult mouse results in loss of HSCs causing multilineage bone marrow failure and increased lethality. In contrast, conditional ablation of Cited2 after lineage specification in lymphoid and myeloid lineages has no impact on the maintenance of these lineages. Additional deletion of Ink4a/Arf (encoding p16(Ink4a) and p19(Arf)) or Trp53 (encoding p53, a downstream target of p19(Arf)) in a Cited2-deficient background restores HSC functionality and rescues mice from bone marrow failure. Furthermore, we show that the critical role of Cited2 in primitive hematopoietic cells is conserved in humans. Taken together, our studies provide genetic evidence that Cited2 selectively maintains adult HSC functions, at least in part, via Ink4a/Arf and Trp53.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available